Rare diseases
Investigational molecules
Locations
211 Mount Airy Road, 07920-2311, United States
Daiichi Sankyo Inc. funds a broad portfolio in HER2-positive, HER2-low, and HER2-expressing cancers, with work spanning breast cancer, gastric cancer, gastroesophageal junction adenocarcinoma, endometrial cancer, and ovarian cancer. Its studies also include treatment settings for metastatic solid tumors and locally advanced disease.
The sponsor also supports studies in adjuvant breast cancer and other HER2-driven malignancies across multiple tumour types.
Daiichi Sankyo Inc. runs clinical trials in conditions such as Non-small cell lung cancer, Ovarian cancer, Neoplasm, Transitional cell carcinoma, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Belgium
FranceFranceBelgium
AustriaAustriaAustriaBelgiumFranceAustriaBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
